Literature DB >> 7081975

Uptake, distribution, and anabolism of acyclovir in herpes simplex virus-infected mice.

K K Biron, J E Noblin, P de Miranda, G B Elion.   

Abstract

The uptake, distribution, and anabolism of the nucleoside analog 9-(2-hydroxyethoxymethyl) guanine (acyclovir) were compared in herpes simplex virus-infected and uninfected mice. Analyses of tissue distribution and the concentration of acyclovir after either a single dose or multiple doses failed to reveal significant differences between drug levels in infected and uninfected animals. Extracts of tissues from [8-14C] acyclovir-treated animals were examined by high-performance liquid chromatography to detect the presence of any phosphorylated forms of the drug. The sensitivity of this method did not allow a reproducible demonstration of acyclovir anabolism in herpes simplex virus-infected tissues owing to the low numbers of infected cells per organ.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7081975      PMCID: PMC181826          DOI: 10.1128/AAC.21.1.44

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Authors:  G B Elion; P A Furman; J A Fyfe; P de Miranda; L Beauchamp; H J Schaeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acid.

Authors:  E R Kern; J T Richards; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

3.  9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

Authors:  H J Schaeffer; L Beauchamp; P de Miranda; G B Elion; D J Bauer; P Collins
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

4.  Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.

Authors:  R J Klein; A E Friedman-Kien; E DeStefano
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

5.  Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate.

Authors:  P A Furman; M H St Clair; J A Fyfe; J L Rideout; P M Keller; G B Elion
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

6.  Treatment of experimental herpes simplex keratitis with acycloguanosine.

Authors:  D J Bauer; P Collins; W E Tucker; A W Macklin
Journal:  Br J Ophthalmol       Date:  1979-06       Impact factor: 4.638

7.  The activity in vitro against herpes virus of 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine), a new antiviral agent.

Authors:  P Collins; D J Bauer
Journal:  J Antimicrob Chemother       Date:  1979-07       Impact factor: 5.790

8.  A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine].

Authors:  R P Quinn; P de Miranda; L Gerald; S S Good
Journal:  Anal Biochem       Date:  1979-10-01       Impact factor: 3.365

9.  Acycloguanosine: antiviral activity in the rabbit cornea.

Authors:  M G Falcon; B R Jones
Journal:  Br J Ophthalmol       Date:  1979-06       Impact factor: 4.638

10.  Therapy of experimental herpes simplex encephalitis with aciclovir in mice.

Authors:  N H Park; D Pavan-Langston; S L McLean; D M Albert
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

View more
  10 in total

1.  Drug combinations for treatment of mice infected with acyclovir-resistant herpes simplex virus.

Authors:  R F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

2.  Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs.

Authors:  F S Hasnie; J Breuer; S Parker; V Wallace; J Blackbeard; I Lever; P R Kinchington; A H Dickenson; T Pheby; A S C Rice
Journal:  Neuroscience       Date:  2006-12-29       Impact factor: 3.590

3.  Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.

Authors:  R F Schinazi; J J Fox; K A Watanabe; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

4.  Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculated mice.

Authors:  L R Crane; D A Milne; J C Sunstrum; A M Lerner
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

5.  Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus.

Authors:  R F Schinazi; J Peters; M K Sokol; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

Review 6.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

7.  Fluorescent xDNA nucleotides as efficient substrates for a template-independent polymerase.

Authors:  Sarah K Jarchow-Choy; Andrew T Krueger; Haibo Liu; Jianmin Gao; Eric T Kool
Journal:  Nucleic Acids Res       Date:  2010-10-14       Impact factor: 16.971

8.  N-Methanocarbathymidine is more effective than acyclovir for treating neonatal herpes simplex virus infection in guinea pigs.

Authors:  David I Bernstein; Fernando J Bravo; Jennifer R Clark; Julie D Earwood; Aquilur Rahman; Robert Glazer; Rhonda D Cardin
Journal:  Antiviral Res       Date:  2011-09-07       Impact factor: 10.103

Review 9.  Herpesviruses--a rationale for antiviral treatment in multiple sclerosis.

Authors:  T Bergström
Journal:  Antiviral Res       Date:  1999-02       Impact factor: 5.970

10.  Trifluorothymidine: potential non-invasive diagnosis of herpes simplex infection using 19F nuclear magnetic resonance in a murine hepatitis model.

Authors:  K H Rand; I Raad; A el Koussi; H J Houck; W Brey; J Rocca; T Loftsson; N Bodor
Journal:  J Virol Methods       Date:  1987-12       Impact factor: 2.014

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.